文献速递鼻科

慢性肾病及终末期肾病合并慢性鼻窦炎患者的微生物分析

Microbial Analysis in Chronic Rhinosinusitis Patients with Chronic Kidney Disease and End-Stage Renal Disease.
PubMed 文献 · Laryngoscope · 2024-03-09

本研究回顾性分析长庚研究数据库中2004至2018年接受鼻窦手术的13906例住院患者,比较终末期肾病合并慢性鼻窦炎(ESRD-CRS)、慢性肾病合并慢性鼻窦炎(CKD-CRS)与非肾病慢性鼻窦炎患者的细菌培养结果,发现ESRD-CRS以肺炎克雷伯菌为主,CKD-CRS以表皮葡萄球菌为主,为临床抗生素选择提供依据。

要点

  • ESRD-CRS主要菌种为肺炎克雷伯菌(31.6%)、铜绿假单胞菌(21.1%)和凝固酶阴性葡萄球菌(15.8%)。
  • CKD-CRS主要菌种为表皮葡萄球菌(27.7%)、凝固酶阴性葡萄球菌(20.5%)和铜绿假单胞菌(20.5%)。
  • ESRD-CRS厌氧菌以具核梭杆菌(10.5%)和微小消化链球菌(10.5%)为主。

核心结论

  • 对于终末期肾病合并慢性鼻窦炎,推荐使用针对肺炎克雷伯菌和具核梭杆菌的抗生素。
  • 对于慢性肾病合并慢性鼻窦炎,建议关注表皮葡萄球菌和痤疮丙酸杆菌。

研究设计与样本

  • 回顾性分析长庚研究数据库中2004至2018年接受鼻窦手术的13906例住院患者。
  • 根据估算肾小球滤过率将患者分为ESRD-CRS组47例、CKD-CRS组230例和非CKD-CRS组13123例。
  • 对手术样本进行细菌培养,分为兼性厌氧菌或需氧菌、厌氧菌和真菌,并按患病率排序。

主要发现

  • ESRD-CRS组主要菌种为肺炎克雷伯菌31.6%、铜绿假单胞菌21.1%、凝固酶阴性葡萄球菌15.8%。
  • CKD-CRS组主要菌种为表皮葡萄球菌27.7%、凝固酶阴性葡萄球菌20.5%、铜绿假单胞菌20.5%。
  • 非CKD-CRS组主要菌种为表皮葡萄球菌29.8%、凝固酶阴性葡萄球菌25.0%、金黄色葡萄球菌15.5%。
  • ESRD-CRS组厌氧菌以具核梭杆菌10.5%和微小消化链球菌10.5%为主。
  • CKD-CRS组和非CKD-CRS组厌氧菌以痤疮丙酸杆菌为主要菌株,分别为14.5%和28.7%。

临床怎么用

  • 对于终末期肾病合并慢性鼻窦炎,推荐使用针对肺炎克雷伯菌和具核梭杆菌的抗生素。
  • 对于慢性肾病合并慢性鼻窦炎,建议关注表皮葡萄球菌和痤疮丙酸杆菌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study aimed to elucidate the bacterial profile of chronic rhinosinusitis (CRS) in patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD) compared with nonrenal patients, guiding antibiotic selection for clinicians. METHODS: We retrospectively analyzed 13,906 inpatients from the Chang Gung Research Database who underwent sinus surgery (2004-2018). Patients were categorized into ESRD-CRS, CKD-CRS, and non-CKD-CRS based on the estimated glomerular filtration rate. Bacterial cultures from surgical samples were classified as facultative anaerobes or aerobes (e.g., Klebsiella pneumoniae [KP], Pseudomonas aeruginosa [Ps.a]), anaerobes, and fungi and ranked by prevalence. RESULTS: Data from 47 ESRD-CRS, 230 CKD-CRS, and 13,123 non-CKD-CRS patients were analyzed. In ESRD-CRS, the predominant species were KP (31.6%), Ps.a (21.1%), and Coagulase-negative Staphylococcus (CoNS, 15.8%). CKD-CRS showed Staphylococcus epidermidis (27.7%), CoNS (20.5%), and Ps.a (20.5%). Non-CKD-CRS had Staphylococcus epidermidis (29.8%), CoNS (25.0%), and Staphylococcus aureus (15.5%). For anaerobes, ESRD-CRS was dominated by Fusobacterium nucleatum (10.5%) and Peptostreptococcus micros (10.5%), whereas CKD-CRS and non-CKD-CRS showed Propionibacterium acnes as a primary strain (14.5% and 28.7%, respectively). CONCLUSION: For CRS in ESRD, antibiotics targeting KP and Fusobacterium nucleatum are recommended. In CKD-CRS, a focus on Staphylococcus epidermidis and Propionibacterium acnes is suggested. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:3499-3507, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lo SW, Ding MC, Tsai YT, et al. Microbial Analysis in Chronic Rhinosinusitis Patients with Chronic Kidney Disease and End-Stage Renal Disease. Laryngoscope. 2024. PMID: 38459950. doi:10.1002/lary.31389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。